Lord, Abbett & Co
PAHC icon

Lord, Abbett & Co’s Phibro Animal Health PAHC Stock Holding History

Lord, Abbett & Co’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5M Buy
653,305
+255,591
+64% +$10.8M 0.06% 303
2026
Q1 		$22M Buy
397,714
+256,505
+182% +$12.2M 0.07% 262
2025
Q4 		$5.28M Buy
141,209
+4,945
+4% +$201K 0.02% 457
2025
Q3 		$5.51M Buy
+136,264
New +$4.5M 0.02% 453

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return

Lord, Abbett & Co's PAHC Position: Q2 2026 in Review

Lord, Abbett & Co increased its Phibro Animal Health (PAHC) stake by 64% in Q2 2026, buying an estimated $10.8M and bringing the position to 653,305 shares worth $20.5M. The position accounts for 0.06% of the portfolio, ranked #303.

Lord, Abbett & Co first reported a position in PAHC in Q3 2025 and has held it in 4 quarters since. The position peaked at $22M in Q1 2026. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Lord, Abbett & Co held 653,305 shares of Phibro Animal Health worth $20.5M as of Q2 2026.
  • Lord, Abbett & Co bought 255,591 Phibro Animal Health shares in Q2 2026, an estimated $10.8M.
  • Phibro Animal Health made up 0.06% of Lord, Abbett & Co's portfolio in Q2 2026, its #303 holding.
  • Lord, Abbett & Co first reported a position in Phibro Animal Health in Q3 2025 and has held it in 4 quarters since.
  • Lord, Abbett & Co's Phibro Animal Health position peaked at $22M in Q1 2026.
  • 209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.